Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Advisory committee meeting cancellation announced

April 8, 1998

Abbott discovers new agents for controlling synaptic transmission

April 8, 1998

Study shows Quadramet provides significant relief from bone pain

April 8, 1998

Warner-Lambert announces collaboration with Forest

April 8, 1998

Neurokinin A: a peptide with a potential role in the perception of pain

April 8, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Metabasis Therapeutics and Pfizer extend ARA research collaboration

April 7, 1998

Orphan Medical announces Xyrem clinical trial results

April 3, 1998

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...